Litcius/Paper detail

Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway

Nidhi Sharma, Taslim B. Shaikh, Abhisheik Eedara, Madhusudhana Kuncha, Ramakrishna Sistla, Sai Balaji Andugulapati

2022European Journal of Pharmacology24 citationsDOI

Topics & Concepts

ThioacetamideHepatic stellate cellHepatic fibrosisFibrosisIn vivoMAPK/ERK pathwayPathogenesisPathologyMyeloperoxidaseLiver injuryOxidative stressMedicineSignal transductionChemistryBiologyCancer researchInflammationInternal medicineCell biologyBiotechnologyLiver physiology and pathologyWnt/β-catenin signaling in development and cancerFibroblast Growth Factor Research
Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway | Litcius